Literature DB >> 18833815

Expression of cytokeratin 19 and protein p63 in fine needle aspiration biopsy of papillary thyroid carcinoma.

Mariella Bonzanini1, Pier Luigi Amadori, Carlo Sagramoso, Paolo Dalla Palma.   

Abstract

OBJECTIVE: To analyze the immunocytochemical distribution of CK19 and p63 on archival cytologic smears of 27 papillary thyroid carcinomas (PTCs), 22 benign thyroid lesions and 5 malignant non-PTC lesions. STUDY
DESIGN: Archival cytologic smears of 27 papillary carcinomas, 22 benign thyroid lesions and 5 malignant nonpapillary carcinomas were processed for immunocytochemical detection of CK19 and p63, and results were compared.
RESULTS: CK19 showed strong cytoplasmic staining in 22/27 fine needle aspiration biopsies (FNABs) of PTCs, in 5 benign lesions and in 4 malignant lesions of the control group. p63 Positivity was present in FNABs of 20/27 PTC and in 1 FNAB of nodular hyperplasia. Eighteen FNABs of PTC (66.6%) showed both strong CK19 staining and p63-positive cells, whereas none of the control cases showed coexpression of CK19 and p63.
CONCLUSION: Coexistence of strong CK19 positivity and p63-positive cells can enhance the cytologic diagnosis of PTC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18833815     DOI: 10.1159/000325595

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  7 in total

1.  Expression of p63 and Bcl-2 in Malignant Thyroid Tumors and their Correlation with other Diagnostic Immunocytochemical Markers.

Authors:  Ashumi Gupta; Shyama Jain; Nita Khurana; Arun Kumar Kakar
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma.

Authors:  Zeming Liu; Pan Yu; Yiquan Xiong; Wen Zeng; Xiaoyu Li; Yusufu Maiaiti; Shuntao Wang; Haiping Song; Lan Shi; Chunping Liu; Bo Cheng; Bo Zhang; Jie Ming; Fang Dong; Hui Ge; Xiu Nie; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Systematic Review and Meta-Analysis to Identify the Immunocytochemical Markers Effective in Delineating Benign from Malignant Thyroid Lesions in FNAC Samples.

Authors:  Uma Mohan; Sumsum P Sunny; Pramila Mendonca; Moni A Kuriakose; Subramanian Kannan; Amritha Suresh
Journal:  Endocr Pathol       Date:  2022-05-21       Impact factor: 4.056

Review 4.  Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View.

Authors:  Sadegh Rajabi; Catherine Alix-Panabières; Arshia Sharbatdar Alaei; Raziyeh Abooshahab; Heewa Shakib; Mohammad Reza Ashrafi
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

Review 5.  New Insights in Thyroid Cancer and p53 Family Proteins.

Authors:  Livia Manzella; Stefania Stella; Maria Stella Pennisi; Elena Tirrò; Michele Massimino; Chiara Romano; Adriana Puma; Martina Tavarelli; Paolo Vigneri
Journal:  Int J Mol Sci       Date:  2017-06-21       Impact factor: 5.923

Review 6.  Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis.

Authors:  Leandro Luongo de Matos; Adriana Braz Del Giglio; Carolina Ogawa Matsubayashi; Michelle de Lima Farah; Auro Del Giglio; Maria Aparecida da Silva Pinhal
Journal:  Diagn Pathol       Date:  2012-08-13       Impact factor: 2.644

7.  Cytomorphologic Diversity of Papillary Thyroid Carcinoma.

Authors:  Vidya Monappa; Ranjini Kudva
Journal:  J Cytol       Date:  2017 Oct-Dec       Impact factor: 1.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.